American Journal of Neuroradiology, Vol 19, Issue 6 1047-1054, Copyright © 1998 by American Society of Neuroradiology
ARTICLES |
Cerebral N-acetylaspartate is low in patients with multiple sclerosis and abnormal visual evoked potentials
AC Heide, GH Kraft, JC Slimp, JC Gardner, S Posse, S Serafini, JD Bowen and TL Richards
Department of Radiology, University of Washington, Seattle, USA.
PURPOSE: Our purpose was to compare cerebral proton MR metabolite changes in patients with multiple sclerosis (MS) and abnormal visual evoked potentials (VEPs) with those in MS patients with normal VEPs. METHODS: Seventeen subjects with clinically definite MS were studied with VEPs and MR spectroscopic imaging. Proton MR metabolites were measured using a fast spectroscopic imaging technique called proton echo-planar spectroscopic imaging (PEPSI). Kurtzke's Expanded Disability Status Scale (EDSS) score was also ascertained for each subject to obtain a clinical rating. Twelve regions of interest within the visual pathway of the cerebrum were evaluated for levels of N- acetylaspartate (NAA), choline, creatine, and the presence or absence of MR-detectable lesions. RESULTS: PEPSI NAA values (water-normalized, CSF-corrected) were significantly lower in MS subjects with abnormal VEPs than in subjects with normal VEPs. MR-detectable lesion fractions and EDSS scores were also significantly different between the two VEP groups, but NAA comparison had a P value 100 times less than either of these measures. CONCLUSION: In patients with MS, NAA measurements in the optic pathways of the brain were sensitive to VEP abnormalities. NAA was more sensitive to VEP changes than were choline, creatine, MR- detectable lesions, and EDSS score.
This article has been cited by other articles:
 |
|
 |
|
  G. Gillson, T. Richards, R. Smith, and J. Wright A double-blind pilot study of the effect of ProkarinTM on fatigue in multiple sclerosis Multiple Sclerosis, September 1, 2002; 8(1_suppl): 30 - 35. [Abstract] [PDF]
|
|
|
|
|
|
G Gillson, T L Richards, R B Smith, and J V Wright A double-blind pilot study of the effect of ProkarinTM on fatigue in multiple sclerosis Multiple Sclerosis, February 1, 2002; 8(1): 30 - 35. [Abstract] [PDF]
|
|